Kiniksa Pharmaceuticals Ltd
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.3 | 5.8 | 3.8 | 4.4 | – | 90.3 | 160.9 | – | – | – | – | 450.7 | 84.3 | 55.3 | 54.4 | 66.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 123.4 | 39.5 | 21.1 | 9.7 | 7.5 | 5.1 | 4.9 | 3.2 | 3.6 | 4.9 | 4.7 | 4.6 | 3.9 | 4.7 | 3.4 | 3.5 | 4.1 | 5.1 | 4.8 | 5.3 | 6.3 | |
| – | – | – | – | – | – | 0.9 | 3.9 | 4.9 | 3.1 | 2.7 | 1.9 | 2.7 | 4.2 | 5.9 | 2.8 | 3.9 | 4.7 | 4.0 | 3.7 | 4.4 | 4.1 | 4.4 | 2.4 | 2.7 | 1.9 | 2.5 | 3.0 | 2.9 | 3.2 | 3.1 | 4.1 | 3.3 | 3.7 | 4.4 | 5.7 | 5.7 | 6.6 | 8.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 101.9 | 30.1 | 18.0 | 8.8 | 6.5 | 4.1 | 4.3 | 2.9 | 3.2 | 4.4 | 4.3 | 4.2 | 3.6 | 4.4 | 3.0 | 3.2 | 3.7 | 4.8 | 4.6 | 5.0 | 6.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 62.4 | 23.2 | 19.1 | – | – | – | – | – | – | – | 124.9 | 57.0 | 34.3 | 35.2 | 46.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 187.7 | 19.7 | 23.8 | – | 96.5 | 65.1 | 43.8 | 161.5 | 56.3 | 38.7 | 32.5 | 29.8 | 23.9 | 24.2 | 29.2 | |
| – | – | – | – | – | – | -21.2% | -6.4% | -6.3% | -14.5% | -21.6% | -35.8% | -26.5% | -15.0% | -7.9% | -12.1% | -11.4% | -13.1% | -18.4% | -21.6% | -18.0% | -18.0% | -13.8% | -0.2% | 0.5% | 5.1% | 4.2% | -0.2% | 1.0% | 1.5% | 2.3% | 0.6% | 1.8% | 2.6% | 3.1% | 3.4% | 4.2% | 4.1% | 3.4% | |
| Margins | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 68.7% | 65.0% | 65.5% | 77.6% | 77.2% | 77.6% | 76.5% | 67.5% | 65.5% | 64.1% | 62.2% | 60.9% | 55.2% | 54.3% | 53.1% | 52.8% | 54.6% | 54.6% | 54.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,413.7% | -875.8% | -406.4% | -184.7% | -121.6% | -18.3% | 4.4% | 9.3% | 13.6% | -7.7% | -9.3% | -10.1% | -8.1% | -6.8% | -10.8% | -3.3% | 0.8% | 6.4% | 11.4% | 12.4% | 11.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,447.3% | -885.1% | -409.7% | -188.9% | -124.5% | 80.5% | 83.3% | 83.1% | 82.3% | -2.7% | 5.2% | 2.9% | -3.0% | -2.4% | -10.2% | -3.5% | 0.9% | 6.0% | 8.7% | 9.7% | 9.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,266.2% | -852.7% | -380.6% | -174.4% | -102.8% | -1.1% | 2.6% | 16.2% | 15.1% | -1.1% | 4.9% | 7.1% | 8.9% | 2.9% | 6.0% | 9.1% | 12.6% | 17.0% | 20.1% | 21.8% | 21.8% | |
| Returns | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | -36.9% | -24.9% | -29.3% | -37.0% | -49.9% | -61.8% | -68.5% | -71.8% | -59.5% | -49.0% | -38.9% | -51.7% | -68.1% | -80.0% | -81.9% | -85.3% | -80.4% | -73.0% | 37.1% | 46.3% | 50.3% | 56.2% | -1.7% | 3.2% | 2.0% | -2.4% | -2.1% | -9.9% | -3.7% | 1.0% | 6.7% | 10.4% | 12.1% | 12.3% | |
| – | – | – | – | -136.6% | -33.8% | -23.3% | -26.9% | -32.1% | -44.2% | -55.2% | -61.3% | -63.6% | -54.2% | -45.2% | -36.3% | -46.2% | -59.3% | -67.5% | -69.3% | -67.8% | -57.9% | -53.2% | 31.0% | 39.9% | 44.3% | 47.7% | -1.4% | 2.7% | 1.7% | -1.9% | -1.6% | -7.4% | -2.8% | 0.7% | 5.0% | 7.7% | 8.9% | 9.0% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -286 | -338 | – | -323 | -286 | -257 | -45 | -105 | -122 | -84 | -112 | -117 | -165 | -187 | -119 | -60 | -91 | -172 | -119 | -77 | -110 | -116 | -106 | -139 | -97 | -95 | -182 | -155 | -190 | -172 | -163 | -187 | -172 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.8 | -2.6 | -2.3 | – | – | – | – | – | – | – | -12.0 | -3.4 | -1.8 | -1.7 | -1.5 | |
| 95.9% | – | – | – | -188.9% | 91.4% | 93.6% | 91.9% | 86.7% | 88.5% | 89.3% | 89.4% | 88.6% | 91.0% | 92.3% | 93.3% | 89.3% | 87.0% | 84.4% | 84.7% | 79.5% | 72.0% | 72.9% | 83.5% | 86.2% | 88.1% | 85.0% | 83.9% | 83.4% | 83.1% | 80.2% | 78.7% | 75.5% | 76.3% | 74.9% | 75.2% | 74.3% | 73.4% | 73.0% | |
| – | – | – | – | – | – | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | |||||||||||||||||||||||||||||||||||||||
| – | – | – | -1.73 | -2.00 | -1.62 | -4.64 | -1.94 | -2.13 | -2.96 | -3.12 | -3.15 | -2.95 | -2.21 | -2.12 | -2.12 | -2.37 | -2.70 | -2.76 | -2.55 | -2.29 | -1.93 | -1.62 | 2.02 | 2.57 | 2.81 | 3.23 | -0.10 | 0.19 | 0.12 | -0.14 | -0.13 | -0.60 | -0.22 | 0.06 | 0.46 | 0.75 | 0.89 | 0.97 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.29 | 0.56 | 1.02 | 1.30 | 2.51 | 3.09 | 3.39 | 3.92 | 3.54 | 3.72 | 4.27 | 4.77 | 5.35 | 5.85 | 6.32 | 6.79 | 7.66 | 8.58 | 9.15 | 10.08 | |
| – | 1.67 | – | – | -2.76 | 4.38 | 18.65 | 6.62 | 5.76 | 5.92 | 5.05 | 4.59 | 4.11 | 3.72 | 4.32 | 5.44 | 4.58 | 3.97 | 3.45 | 3.12 | 2.68 | 2.40 | 2.22 | 5.44 | 5.55 | 5.59 | 5.75 | 5.77 | 6.04 | 6.11 | 6.13 | 6.09 | 6.06 | 6.01 | 6.35 | 6.86 | 7.19 | 7.35 | 7.84 | |
| – | – | – | – | -1.55 | -1.27 | -3.69 | -1.62 | -1.78 | -2.63 | -2.92 | -3.05 | -2.94 | -2.33 | -2.02 | -1.85 | -2.01 | -2.42 | -2.55 | -2.46 | -2.13 | -1.78 | -1.33 | -0.03 | 0.08 | 0.55 | 0.59 | -0.04 | 0.18 | 0.30 | 0.43 | 0.15 | 0.35 | 0.57 | 0.85 | 1.30 | 1.73 | 1.99 | 2.20 | |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.